1. Home
  2. TENX vs LXEH Comparison

TENX vs LXEH Comparison

Compare TENX & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • LXEH
  • Stock Information
  • Founded
  • TENX 1967
  • LXEH 2001
  • Country
  • TENX United States
  • LXEH China
  • Employees
  • TENX 6
  • LXEH N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • LXEH Other Consumer Services
  • Sector
  • TENX Health Care
  • LXEH Real Estate
  • Exchange
  • TENX Nasdaq
  • LXEH Nasdaq
  • Market Cap
  • TENX 21.6M
  • LXEH 25.1M
  • IPO Year
  • TENX N/A
  • LXEH 2020
  • Fundamental
  • Price
  • TENX $5.53
  • LXEH $2.33
  • Analyst Decision
  • TENX Strong Buy
  • LXEH
  • Analyst Count
  • TENX 3
  • LXEH 0
  • Target Price
  • TENX $16.00
  • LXEH N/A
  • AVG Volume (30 Days)
  • TENX 18.4K
  • LXEH 250.2K
  • Earning Date
  • TENX 05-13-2025
  • LXEH 04-29-2025
  • Dividend Yield
  • TENX N/A
  • LXEH N/A
  • EPS Growth
  • TENX N/A
  • LXEH N/A
  • EPS
  • TENX N/A
  • LXEH N/A
  • Revenue
  • TENX N/A
  • LXEH $5,628,870.00
  • Revenue This Year
  • TENX N/A
  • LXEH N/A
  • Revenue Next Year
  • TENX N/A
  • LXEH N/A
  • P/E Ratio
  • TENX N/A
  • LXEH N/A
  • Revenue Growth
  • TENX N/A
  • LXEH N/A
  • 52 Week Low
  • TENX $2.77
  • LXEH $1.53
  • 52 Week High
  • TENX $7.89
  • LXEH $50.08
  • Technical
  • Relative Strength Index (RSI)
  • TENX 42.57
  • LXEH 31.75
  • Support Level
  • TENX $4.63
  • LXEH $1.53
  • Resistance Level
  • TENX $5.75
  • LXEH $23.50
  • Average True Range (ATR)
  • TENX 0.42
  • LXEH 6.56
  • MACD
  • TENX -0.04
  • LXEH -2.98
  • Stochastic Oscillator
  • TENX 47.70
  • LXEH 1.86

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: